The role of nursing in improving pain management and functional status in children with gastroenteritis using evidence-based guidelines
Abstract
Introduction: Pediatric gastroenteritis is a critical inflammatory condition affecting the stomach and intestines, characterized by acute diarrhea, vomiting, and abdominal pain. Often accompanied by fever and dehydration, these symptoms typically persist for less than two weeks. Despite the common misnomer “stomach flu,” gastroenteritis remains a leading global health challenge. In 2011, approximately 1.7 billion cases were recorded, resulting in nearly 700,000 deaths among children under the age of five, with the highest prevalence in developing nations. Acute gastroenteritis remains a leading cause of morbidity among children globally, characterized by symptoms such as diarrhea, vomiting, and abdominal cramps, often resulting in dehydration and significant discomfort. In children, these symptoms are not only physically distressing but frequently impair functional status, including oral intake, activity levels, sleep, and participation in normal daily routines. Objective: The primary objective of this study is to assess the nursing role in pain assessment and functional-status monitoring for children with gastroenteritis, with an emphasis on alignment with evidence-based guideline recommendations within clinical settings. Methodology: A descriptive correlational (cross-sectional) design was used to assess nursing practices related to pain and functional-status assessment in pediatric gastroenteritis at Al-Khansaa Teaching Hospital and Ibn Al-Atheer Teaching Hospital in…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 700,000 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.